pubmed.ncbi.nlm.nih.gov

In vivo growth factor treatment of degenerated intervertebral discs - PubMed

️Thu Jan 01 2004

In vivo growth factor treatment of degenerated intervertebral discs

Andrew J L Walsh et al. Spine (Phila Pa 1976). 2004.

Abstract

Study design: An in vivo model was used to investigate the response of degenerated discs to various exogenous growth factors.

Objectives: To study growth factor-induced alterations of the spatial and temporal patterns of disc cellularity and matrix gene expression.

Summary of background data: Cell proliferation and proteoglycan synthesis have been stimulated by growth factors in normal disc cells, suggesting that growth factors may play a therapeutic role for degeneration. However, the response in situ in degenerated discs has not been characterized.

Methods: Degeneration was induced in murine caudal discs by static compression. Degenerated discs were given single or multiple injections of growth and differentiation factor-5, transforming growth factor-beta, insulin-like growth factor-1, basic fibroblast growth factor, or saline as control. Comparisons of disc morphology, anular cell density, proliferating cells, disc height, and aggrecan and type II collagen gene expression were made either 1 week or 4 weeks after treatment.

Results: In some growth and differentiation factor-5 and transforming growth factor-beta treated discs, expansion of inner anular fibrochondrocyte populations into the nucleus was observed. The cells actively expressed aggrecan and type II collagen mRNA. A lesser effect was observed for insulin-like growth factor-1 and little or no effect for basic fibroblast growth factor. Differences in cell density and proliferating cells were not significant between treatments but suggested a trend of increased cellularity and proliferation following growth factor treatment. A statistically significant increase in disc height 4 weeks after growth and differentiation factor-5 treatment was measured.

Conclusions: Anular fibrochondrocytes in degenerated discs are responsive to some growth factors in vivo. The results have implications in the early intervention of disc degeneration to arrest or slow the degenerative process.

PubMed Disclaimer

Cited by

Molecular and genetic advances in the regeneration of the intervertebral disc.
Maerz T, Herkowitz H, Baker K. Maerz T, et al. Surg Neurol Int. 2013 Mar 22;4(Suppl 2):S94-S105. doi: 10.4103/2152-7806.109449. Print 2013. Surg Neurol Int. 2013. PMID: 23646279 Free PMC article.
Biological repair of the degenerated intervertebral disc by the injection of growth factors.
Masuda K. Masuda K. Eur Spine J. 2008 Dec;17 Suppl 4(Suppl 4):441-51. doi: 10.1007/s00586-008-0749-z. Epub 2008 Nov 13. Eur Spine J. 2008. PMID: 19005698 Free PMC article. Review.
Inhibition of microRNA-34a prevents IL-1β-induced extracellular matrix degradation in nucleus pulposus by increasing GDF5 expression.
Liu W, Zhang Y, Feng X, Li S, Gao Y, Wang K, Song Y, Yang S, Tu J, Shao Z, Yang C. Liu W, et al. Exp Biol Med (Maywood). 2016 Nov;241(17):1924-1932. doi: 10.1177/1535370216657444. Epub 2016 Jul 5. Exp Biol Med (Maywood). 2016. PMID: 27385596 Free PMC article.
Intervertebral disc degeneration: biological and biomechanical factors.
An HS, Masuda K, Inoue N. An HS, et al. J Orthop Sci. 2006 Oct;11(5):541-52. doi: 10.1007/s00776-006-1055-4. J Orthop Sci. 2006. PMID: 17013747 Free PMC article. No abstract available.
Therapeutic effects of adenovirus-mediated growth and differentiation factor-5 in a mice disc degeneration model induced by annulus needle puncture.
Liang H, Ma SY, Feng G, Shen FH, Joshua Li X. Liang H, et al. Spine J. 2010 Jan;10(1):32-41. doi: 10.1016/j.spinee.2009.10.006. Epub 2009 Nov 18. Spine J. 2010. PMID: 19926342 Free PMC article.

In vivo growth factor treatment of degenerated intervertebral discs - PubMed